Federal law (42 CFR 483.128) mandates that states provide a Level I screen for all applicants to Medicaid-certified nursing facilities to identify residents with serious mental illness (SMI), Intellectual or Developmental Disabilities (IDD), or a related condition (RC). For residents with no evidence or diagnosis of SMI, IDD, or RC, the initial Level I screen remains valid unless there is a significant change in status.
Referred to as the Level I or identification screen, specific diagnostic and functional questions about an individual are raised to identify those persons with mental illness, Intellectual or Developmental Disabilities, and related conditions. The Level I and, when required, the Level II screens must be performed prior to nursing facility admission (excluding those situations discussed in Section II.D.ii of this manual).
A Level I screen remains valid unless there is a significant change in a resident's status that affects his/her mental health or Intellectual or Developmental Disabilities treatment needs. This means that if a resident is discovered to have SMI, IDD or RC after the Level I was performed, the receiving facility must call the PASRR contractor to perform an updated Level I. Updates to the Level I should also occur if a resident in the PASRR process exhibits an increase in behavioral problems or symptoms or if an individual with IDD makes significant medical improvement and may be a candidate for special treatment services. Level I screens do not need to be done again except when a resident with known or suspected SMI, IDD or RC has not been previously assessed through the PASRR contractor or if no prior Level I has been completed.
It is the responsibility of the referral source to initiate the Level I screen with DXC Technology before an applicant is admitted to a nursing facility. Admitting facilities are then responsible for re-initiating contact for residents meeting the criteria explained in Section II.D of this manual. Failure to notify DXC Technology of a patient's admission may result in a lapse in the screenings for Level II PASRR individuals.
The Division of Mental Health, Developmental Disabilities, and Substance Abuse Services (DMH/DD/SAS) PASRR Unit is the agency which will make final determinations regarding appropriateness of placement and need for specialized services and, in cases where specialized services are determined as necessary, the DMH/DD/SAS will arrange for provision of those services.
Other than the exceptions noted above, all applicants for admission to Medicaid certified nursing facilities must have a Level I PASRR screen to determine the potential presence of serious mental illness,mental retardation, or a related condition prior to their admission to nursing facility care. Each of these conditions is defined in Section IV.D.
As a result of the Level I screen, the following outcomes may occur that include a negative or positive finding for the patient's eligibility for the PASRR population either with a serious mental illness, Intellectual or Developmental Disabilities, or related condition:
Negative Finding: When the individual is determined to be exempt from the Level II PASRR population ("A" alpha character at the end of the review number) and receives or is applying for Medicaid benefits, the facility should follow general procedures for Medicaid level of care screens through the DXC Technology LTC prior approval unit. The referral source is provided with a PASRR review number which s/he will be required to supply to the DXC Technology LTC staff at the time of that screen. That number must be entered into block ten (10) of the FL2. The DXC Technology LTC department will then issue a Service Review Number (SRN) based upon NF level of care and this number will continue to be used for Medicaid billing purposes. If the individual is approved for admission, the receiving facility must contact DXC Technology upon the individual's admission to request a written copy of the Level I approval for the individual's records.
Negative Finding: When the individual is determined to be exempt from the Level II PASRR population ("A" alpha character at the end of the review number) and is not a Medicaid recipient or applicant, the facility should follow its general admission procedures and the referral source will be provided with notification of this determination through provider link or fax.
Positive Finding: When the individual is found to meet the Level II PASRR criteria by the DXC Technology nurse analyst, the referral source will be asked to forward specific current information identified in Section II.C.i of this manual (e.g., history and physical examination, the MDS, FL-2, physician notes, available intellectual testing, etc.). Upon receipt of that information, the need for a Level II face to face assessment will be determined. If the patient meets federal criteria for Level II status, a referral is initiated by the DXC Technology PASRR nurse and the referral source is notified via Provider Link of the referral status of their request. The review process will be completed within 7 business days of the Level II referral (day of the initial written notification that the patient meets Level II PASRR population criteria). The written notification of the Level II determination will be provided to the referral source by the 7th business day. During the written notification, the facility will be provided with an DXC Technology PASRR number for the screened individual. If that individual is a Medicaid recipient or applicant, the referral source should then initiate contact with the DXC Technology LTC team for nursing facility level of care determination and should provide the assigned DXC Technology PASRR number. The DXC Technology LTC team will then issue an authorization number (also called a service review number) which will be used for Medicaid billing. The receiving facility must contact DXC Technology upon the individual's admission to request a written copy of the Level II approval for the individual's records. This can be accomplished by submitting a tracking form via facsimile, mail, or electronic submission.
When the submitted Level I screen indicates that the individual does have indicators of a serious mental illness or Intellectual or Developmental Disabilities, s/he will be referred for a Level II face-to-face evaluation. The Level II must be completed prior to the individual's admission to a Medicaid certified nursing facility (regardless of whether the individual is a Medicaid recipient or is a private payee). The referral source will be notified of the need for a Level II screen during the initial notification via Provider Link or fax, and the process discussed in Section II.C.i called Pre-admission Screen PAS is initiated. It is important to note that an identified PASRR Level I screen with suspected MI/IDD/RC can not be completed (referred for a face-to-face assessment) until a FL-2 or MDS, and current History and Physical are received by the DXC Technology clinical reviewer.